{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:58:40Z","timestamp":1793354320705,"version":"4.5.0"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":298,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crphar.2022.100138","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T02:44:34Z","timestamp":1666838674000},"page":"100138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions"],"prefix":"10.1016","volume":"3","author":[{"given":"Paul L.R.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin S.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Sanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crphar.2022.100138_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neures.2010.12.019","article-title":"mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain","volume":"69","author":"Aizawa","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.crphar.2022.100138_bib2","first-page":"1031","article-title":"Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis","volume":"28","author":"Alhifany","year":"2020","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.crphar.2022.100138_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115372","article-title":"Growth Differentiation Factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage","author":"Altena","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crphar.2022.100138_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1139\/y90-047","article-title":"The abdominal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity","volume":"68","author":"Andrews","year":"1990","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib189","first-page":"586","article-title":"Anticonvulsive evaluation and histopathological survey of thalidomide synthetic analogs on lithium -pilocarpine-induced status epilepticus in rats","volume":"16","author":"Amanlou","year":"2021","journal-title":"Res. Pharmaceut."},{"key":"10.1016\/j.crphar.2022.100138_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jgh.15261","article-title":"COVID-19, nausea and vomiting","volume":"36","author":"Andrews","year":"2020","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.crphar.2022.100138_bib6","series-title":"Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agent","article-title":"The physiology and pharmacology of nausea and vomiting induced by anti-cancer chemotherapy in humans. P.5-44","author":"Andrews","year":"2015"},{"key":"10.1016\/j.crphar.2022.100138_bib7","series-title":"Making Medicines. A Brief History of Pharmacy and Pharmaceuticals","first-page":"243","article-title":"From arsenic to thalidomide: a brief history of medicine safety","author":"Appelbe","year":"2005"},{"key":"10.1016\/j.crphar.2022.100138_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/1735-5362.272562","article-title":"Synthesis, molecular docking, and antiepileptic activity of novel phthalimide derivatives bearing amino acid conjugated anilines","volume":"14","author":"Asadollahi","year":"2019","journal-title":"Res. Pharmaceutical Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib188","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMe1202819","article-title":"Lenalidomide in myeloma- a high maintenance friend","volume":"366","author":"Badros","year":"2012","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3892\/etm.2012.847","article-title":"Determination of thalidomide concentration in human plasma by liquid chromatography-tandem mass spectrometry","volume":"5","author":"Bai","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib10","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1152\/jn.00038.2008","article-title":"Organization and properties of GABAergic neurones in the solitary tract nucleus (NTS)","volume":"99","author":"Bailey","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.crphar.2022.100138_bib196","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM197909273011318","article-title":"Nabilone as an anti-emetic","volume":"301","author":"Baker","year":"1979","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.crphar.2022.100138_bib11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0028-3908(99)00205-1","article-title":"Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements","volume":"39","author":"Barann","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.crphar.2022.100138_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.1.4591.13","article-title":"Antihistamine drugs in treatment of nausea and vomiting due to streptomycin","volume":"1","author":"Bignall","year":"1949","journal-title":"Br. Med. J."},{"key":"10.1016\/j.crphar.2022.100138_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1213\/00000539-199204000-00013","article-title":"Subhypnotic doses of propofol possess direct antiemetic properties","volume":"74","author":"Borgeat","year":"1992","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.crphar.2022.100138_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0031-6997(25)07328-4","article-title":"Physiology and pharmacology of vomiting","volume":"5","author":"Borison","year":"1953","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.crphar.2022.100138_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","article-title":"GDF15 induces anorexia through nausea and emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.crphar.2022.100138_bib16","series-title":"Animals and Medicine. The Contribution of Animal Experiments to the Control of Disease","article-title":"The history of thalidomide. Chapter 18, p.183-198","author":"Botting","year":"2016"},{"key":"10.1016\/j.crphar.2022.100138_bib17","first-page":"276","article-title":"The antiemetic action of chlorpromazine hydrochloride","volume":"70","author":"Boyd","year":"1954","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.crphar.2022.100138_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)04467-2","article-title":"The antiemetic activity of 10-(7-dimethylaminopropyl)-2-chlorophenpthiazine (chlorpromazine) in dog and cat","volume":"110","author":"Brand","year":"1954","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.crphar.2022.100138_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.crphar.2022.100138_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008329821941","article-title":"Thalidomide in patients with cachexia due to terminal cancer: preliminary report","volume":"10","author":"Bruera","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2020.07.029","article-title":"Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized, placebo- controlled trial","volume":"160","author":"Carlin","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crphar.2022.100138_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.110.2852.215","article-title":"Treatment of nausea and vomiting of pregnancy with Dramamine-preliminary report","volume":"110","author":"Carliner","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.crphar.2022.100138_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/bjc.1988.278","article-title":"Pharmacokinetics and anti-emetic activity of BRL43694, a new selective 5HT-3 antagonist","volume":"58","author":"Cassidy","year":"1988","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.crphar.2022.100138_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000539-200104000-00027","article-title":"The effects of propofol in the area postrema of rats","volume":"92","author":"Cechetto","year":"2001","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.crphar.2022.100138_bib25","first-page":"287","article-title":"What is the functional role of the thalidomide binding protein cereblon?","volume":"2","author":"Chang","year":"2011","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.crphar.2022.100138_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36367-3","article-title":"BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2022.100138_bib27","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.2081-17.2018","article-title":"Cereblon maintains synaptic and cognitive function by regulating BK channel","volume":"38","author":"Choi","year":"2018","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.crphar.2022.100138_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.2017.76.4316","article-title":"Thalidomide for delayed chemotherapy-induced nausea and vomiting: where is its place in therapy?","volume":"36","author":"Chong","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib29","article-title":"Remind me again, what is thalidomide and how did it cause so much harm?","author":"Daemmrich","year":"2015","journal-title":"Conversation"},{"key":"10.1016\/j.crphar.2022.100138_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0006-8993(87)90320-9","article-title":"Immunocytochemical localization of glutamic acid decarboxylase (GAD) and glutamine synthetase (GS) in the area postrema of the cat. Light and electron microscopy","volume":"410","author":"D'Amelio","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.crphar.2022.100138_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11864-020-00804-1","article-title":"The benefits of olanzapine in palliating symptoms","volume":"22","author":"Davis","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ejn.14985","article-title":"Inflammatory pain in peripheral tissue depends on the activation of the TNF-\u03b1 type 1 receptor in the primary afferent neurone","volume":"53","author":"De Magalh\u00e3es","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.crphar.2022.100138_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114727","article-title":"Thalidomide alleviates neuropathic pain through microglial IL-10\/\u03b2-endorphin signaling pathway","volume":"192","author":"Deng","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib191","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cam4.1330","article-title":"Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through release of GDF15","volume":"7","author":"Dong","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.crphar.2022.100138_bib34","first-page":"e171","article-title":"Quantifying the global rates of nausea and vomiting of pregnancy: a meta -analysis","volume":"20","author":"Einarson","year":"2013","journal-title":"J.\u00a0Population Ther. Clin. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib35","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002280100320","article-title":"Clinical pharmacology of thalidomide","volume":"57","author":"Eriksson","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/bja\/77.4.463","article-title":"Antiemetic effect of subhypnotic doses of propofol after thyroidectomy","volume":"77","author":"Ewalenko","year":"1996","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.crphar.2022.100138_bib38","first-page":"352","article-title":"The metabolism of thalidomide: some biological effects of thalidomide and its metabolites","volume":"25","author":"Fabro","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mce.2016.09.017","article-title":"Genetic analysis of hyperemesis gravidarum reveals association with intracellular calcium release channel (RYR2)","volume":"439","author":"Fejzo","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.crphar.2022.100138_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03258-0","article-title":"Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum","volume":"9","author":"Fejzo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crphar.2022.100138_bib41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/a-0661-0287","article-title":"Evidence GDF15 plays a role in familial and recurrent hyperemesis gravidarum. Geburtsh","volume":"78","author":"Fejzo","year":"2018","journal-title":"Frauenheilkd"},{"key":"10.1016\/j.crphar.2022.100138_bib42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/a-0830-1346","article-title":"Analysis of GDF15 and IGFBP7 in hyperemesis gravidarum support causality","volume":"79","author":"Fejzo","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.crphar.2022.100138_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.17129","article-title":"Whole -exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum","author":"Fejzo","year":"2022","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.crphar.2022.100138_bib44","first-page":"1","article-title":"Medicines legislation and regulation in the United Kingdom 1500-2020","volume":"2022","author":"Ferner","year":"2022","journal-title":"Br.J. Clin Pharamcol."},{"key":"10.1016\/j.crphar.2022.100138_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/393377","article-title":"Morning sickness: a mechanism for protecting mother and embryo","volume":"75","author":"Flaxman","year":"2000","journal-title":"Q.\u00a0Rev. Biol."},{"key":"10.1016\/j.crphar.2022.100138_bib46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/bmj.2.5217.1954","article-title":"Is thalidomide to blame?","volume":"2","author":"Florence","year":"1960","journal-title":"Br. Med. J."},{"key":"10.1016\/j.crphar.2022.100138_bib47","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2022.100138_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0022-3565(25)31041-4","article-title":"A\u00a0comparison of thalidomide and pentobarbital- new methods for identifying hypnotic drugs","volume":"203","author":"Frederickson","year":"1977","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.crphar.2022.100138_bib49","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.3399\/bjgp18X700745","article-title":"Nausea and vomiting of pregnancy and resource implications: the NVP impact study","volume":"69","author":"Gadsby","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.crphar.2022.100138_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000010314","article-title":"Nausea and vomiting in pregnancy: an association between symptoms and maternal prostaglandin E2","volume":"50","author":"Gadsby","year":"2000","journal-title":"Gynecol. Obstet. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.crphar.2022.100138_bib51","article-title":"Modulation of gene expression in the glandular and non-glandular regions of the rat stomach after treatment with the anti-cancer drug cisplatin","volume":"128","author":"Gale","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crphar.2022.100138_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00000542-199710000-00010","article-title":"Determination of plasma concentrations of propofol associated with 50% reduction in postoperative nausea","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.crphar.2022.100138_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0090-6980(74)90005-7","article-title":"Acute toxicity of prostaglandins E2, F2\u03b1 and 15(S) 15 methyl prostaglandin E2 methyl esters in the baboon","volume":"7","author":"Ganesan","year":"1974","journal-title":"Prostaglandins"},{"key":"10.1016\/j.crphar.2022.100138_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.109.2832.359.a","article-title":"The prevention and treatment of motion sickness.1. Seasickness","volume":"109","author":"Gay","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.crphar.2022.100138_bib55","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1073\/pnas.1814446115","article-title":"Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs","volume":"115","author":"Gemechu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crphar.2022.100138_bib56","first-page":"194","article-title":"Management of thalidomide toxicity","volume":"1","author":"Ghobrial","year":"2003","journal-title":"Support Oncol"},{"key":"10.1016\/j.crphar.2022.100138_bib57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.128.5.893","article-title":"The ryanodine receptor\/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues","volume":"128","author":"Giannini","year":"1995","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.crphar.2022.100138_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/pmj.79.929.127","article-title":"Thalidomide and its derivatives: emerging from the wilderness","volume":"79","author":"Gordon","year":"2003","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib59","doi-asserted-by":"crossref","first-page":"566e567","DOI":"10.1016\/S0140-6736(00)02586-1","article-title":"Effect of thalidomide on gastrointestinal toxic effects of irinotecan","volume":"356","author":"Govindarajan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2022.100138_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198110153051601","article-title":"Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting","volume":"305","author":"Gralla","year":"1981","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12013-014-9921-8","article-title":"Antiemetic role of thalidomide in a rat model of cisplatin-induced emesis","volume":"70","author":"Han","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.crphar.2022.100138_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmj.2.4409.6","article-title":"Prevention of sea-sickness in assault craft. A report of experiments under tropical conditions","volume":"2","author":"Hill","year":"1945","journal-title":"Br. Med. J."},{"key":"10.1016\/j.crphar.2022.100138_bib64","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.1073\/pnas.1917701117","article-title":"Hypnotic effect of thalidomide is independent of teratogenic ubiquitin\/proteasome pathway","volume":"117","author":"Hirose","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crphar.2022.100138_bib66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1021008016719","article-title":"Double blind study of the sedative effects of thalidomide enantiomers in humans","volume":"26","author":"H\u00f6glund","year":"1998","journal-title":"J.\u00a0Pharamakokinet. Biopharm."},{"key":"10.1016\/j.crphar.2022.100138_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.physbeh.2014.02.038","article-title":"Cisplatin induces neuronal activation and increase central AMPA and NMDA receptor subunit gene expression in mice","volume":"136","author":"Holland","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.crphar.2022.100138_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1c75cd5d-9dde-4ace-8524-a4980745e804","article-title":"Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study","volume":"8","author":"Horn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.crphar.2022.100138_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2022.100138_bib70","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acsptsci.1c00042","article-title":"N-Adamantyl phthalimidine: a new thalidomide-like drug that lacks cereblon binding and mitigates neuronal and synaptic loss, neuroinflammation, and behavioural deficits in traumatic brain injury and LPS challenge","volume":"4","author":"Hsueh","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib71","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/bmc.466","article-title":"Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography","volume":"19","author":"Huang","year":"2005","journal-title":"Biomed. Chromatogr."},{"issue":"215","key":"10.1016\/j.crphar.2022.100138_bib72","first-page":"1","article-title":"Cytostatic-associated vomiting effectively inhibited by domperidone (R33812)","volume":"1","author":"Huys","year":"1978","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2131\/jts.43.671","article-title":"Thalidomide protects against acute pentylenetetrazole and pilocarpine -induced seizures in mice","volume":"43","author":"Islas-Espinoza","year":"2018","journal-title":"J.\u00a0Toxicol. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib74","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.crphar.2022.100138_bib187","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-016-2073-4","article-title":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs","volume":"104","author":"Ito","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.crphar.2022.100138_bib75","doi-asserted-by":"crossref","first-page":"H1429","DOI":"10.1152\/ajpheart.2000.278.5.H1429","article-title":"Thyroid hormone -induced overexpression of functional ryanodine receptors in the rabbit heart","volume":"278","author":"Jiang","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.crphar.2022.100138_bib76","first-page":"430","article-title":"Klinische Erfahrungen mit einem neuen Sedativum","volume":"6","author":"Jung","year":"1956","journal-title":"Arzneim.-Forsch."},{"key":"10.1016\/j.crphar.2022.100138_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00427320","article-title":"Effects of thalidomide and pentobarbital on neuronal activity in the preoptic area during sleep and wakefulness in the cat","volume":"85","author":"Kaitin","year":"1985","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(02)02424-X","article-title":"Actions of prostanoids to induce emesis and defecation in the ferret","volume":"453","author":"Kan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib79","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00001756-199608120-00002","article-title":"Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy","volume":"7","author":"Kanbayashi","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.crphar.2022.100138_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/22.1.113","article-title":"Thalidomide increases both REM and stage 3-4 sleep in human adults: a preliminary study","volume":"22","author":"Kanbayashi","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.crphar.2022.100138_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2982.2008.01210.x","article-title":"IL1\u03b2- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease","volume":"21","author":"Kidd","year":"2009","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.crphar.2022.100138_bib82","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.irn.2016.03.003","article-title":"Protein network interacting with BK channels","volume":"128","author":"Kim","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.crphar.2022.100138_bib83","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/bja\/85.6.898","article-title":"Prevention of postoperative nausea and vomiting by continuous infusion of subhypnotic propofol in female patients receiving intravenous patient-controlled analgesia","volume":"85","author":"Kim","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.crphar.2022.100138_bib84","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1016-8478(23)13028-7","article-title":"The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line","volume":"17","author":"Kim","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.crphar.2022.100138_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1254\/fpj.69.599","article-title":"Electrographic studies of the actions of hypnotic agents. 1. Effect of various hypnotic agents on the sleep and wakefulness cycle in the rabbit","volume":"69","author":"Kimura","year":"1973","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.crphar.2022.100138_bib86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3565(25)26130-4","article-title":"Central nervous system effects of thalidomide","volume":"134","author":"Kuhn","year":"1961","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.crphar.2022.100138_bib87","first-page":"426","article-title":"N-Phthalyl glutamins\u00e4ure-imid","volume":"6","author":"Kunz","year":"1956","journal-title":"Arnseimittelforschung"},{"key":"10.1016\/j.crphar.2022.100138_bib88","first-page":"627","article-title":"Thalidomide\u2014a new nonbarbiturate sleep-inducing drug","volume":"11","author":"Lasagna","year":"1960","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.crphar.2022.100138_bib89","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/nmo.12575","article-title":"NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2)","volume":"27","author":"Lee","year":"2015","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.crphar.2022.100138_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0028-3908(96)00008-1","article-title":"Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret","volume":"35","author":"Lehmann","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.crphar.2022.100138_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","article-title":"Thalidomide and congenital abnormalities","volume":"1","author":"Lenz","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2022.100138_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0197-0186(85)90106-8","article-title":"Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor vagal nucleus of the vagus","volume":"7","author":"Leslie","year":"1985","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.crphar.2022.100138_bib194","doi-asserted-by":"crossref","first-page":"C1393","DOI":"10.1152\/ajpcell.00278.2010","article-title":"KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents","volume":"300","author":"Li","year":"2011","journal-title":"Am. J. Cell Physiol."},{"key":"10.1016\/j.crphar.2022.100138_bib93","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijid.2020.12.023","article-title":"Thalidomide combined with shot-term low -dose glucocorticoid therapy for the treatment of severe COVID-19: a case -series study","volume":"103","author":"Li","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.crphar.2022.100138_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.809270","article-title":"Emerging progress in nausea and vomiting of pregnancy and hyperemesis gravidarum: challenges and opportunities","volume":"8","author":"Liu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110699","article-title":"RNA-Seq reveals inflammatory mechanisms of Xiao-Ban-Xia-Tang decoction to ameliorate cisplatin-induced emesis in a rat pica model","volume":"131","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.crphar.2022.100138_bib96","article-title":"Multi-dimensional and objective assessment of motion sickness susceptibility based on machine learning","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.crphar.2022.100138_bib97","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/030089160909500609","article-title":"Thalidomide improves prevention of chemotherapy-induced gastrointestinal side effects following a modified FOLFOX7 regimen: results of a prospective randomized crossover study","volume":"95","author":"Liu","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.crphar.2022.100138_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.physbeh.2005.04.009","article-title":"Pica - a model of nausea? Species differences in response to cisplatin","volume":"85","author":"Liu","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.crphar.2022.100138_bib99","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.043","article-title":"Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats","volume":"555","author":"Malik","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib100","series-title":"Modern Drug Use. An Enquiry on Historical Principles","author":"Mann","year":"1984"},{"key":"10.1016\/j.crphar.2022.100138_bib101","first-page":"CD007575","article-title":"Interventions for nausea and vomiting in early pregnancy","volume":"9","author":"Matthews","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.crphar.2022.100138_bib102","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-200059040-00005","article-title":"A\u00a0risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy","volume":"59","author":"Mazzotta","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.crphar.2022.100138_bib103","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/bbb\/zbab126","article-title":"Forsythiae Fructus aqueous extract attenuates cisplatin-induced kaolin consumption (pica) by inhibiting NLRP3 inflammasome activation in rats","volume":"85","author":"Meng","year":"2021","journal-title":"Biosci. Biotoech. Biochem."},{"key":"10.1016\/j.crphar.2022.100138_bib104","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","article-title":"Thalidomide and congenital abnormalities","volume":"2","author":"McBride","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2022.100138_bib105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuropharm.2007.11.001","article-title":"Propofol enhances both tonic and phasic inhibitory currents in second -order neurons of the solitary tract nucleus (NTS)","volume":"54","author":"McDougall","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.crphar.2022.100138_bib107","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib106","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molmed.2017.02.006","article-title":"A\u00a0brighter side to thalidomide: its potential use in immunological disorders","volume":"23","author":"Millrine","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib108","first-page":"4781","article-title":"The transforming growth factor-\u00df superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women","volume":"85","author":"Moore","year":"2000","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.crphar.2022.100138_bib109","first-page":"274","article-title":"Mechanisms of action and potential therapeutic uses of thalidomide","volume":"43","author":"Mujagic","year":"2002","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.crphar.2022.100138_bib110","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/S0960-894X(98)00475-2","article-title":"Thalidomide analogs and PDE4 inhibition","volume":"8","author":"Muller","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.crphar.2022.100138_bib111","first-page":"1150","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med. (N. Y., NY, U. S.)"},{"key":"10.1016\/j.crphar.2022.100138_bib112","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/bmj.1.5062.84","article-title":"Antithyroid activity of N-phythalyl glutamic acid imide (K17)","volume":"11","author":"Murdoch","year":"1958","journal-title":"Br. Med. J. January"},{"key":"10.1016\/j.crphar.2022.100138_bib113","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0022-3999(95)00638-9","article-title":"Assessment of the multiple dimensions of nausea: the Nausea Profile (NP)","volume":"40","author":"Muth","year":"1996","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.crphar.2022.100138_bib114","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJM199901213400304","article-title":"Reduction of cisplatin -induced emesis by a selective neurokinin -1 receptor antagonist. L-754,030 Antiemetic trials group","volume":"340","author":"Navari","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crphar.2022.100138_bib115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cne.902550205","article-title":"A\u00a0comparison of GABA- and GAD-like immunoreactivity within the area postrema of the rat and cat","volume":"255","author":"Newton","year":"1987","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.crphar.2022.100138_bib116","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5694\/j.1326-5377.1964.tb133999.x","article-title":"Nausea and vomiting in pregnancy","volume":"1","author":"Newlinds","year":"1964","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.crphar.2022.100138_bib117","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0960-894X(02)00084-7","article-title":"Thalidomide and its analogues as cyclooxygenase inhibitors","volume":"12","author":"Noguchi","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.crphar.2022.100138_bib190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00210-018-1493-5","article-title":"Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine","volume":"391","author":"Obara","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034712","article-title":"Validating the effect of ondansetron and mirtazapine in treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial","volume":"10","author":"Ostenfeld","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.crphar.2022.100138_bib119","first-page":"745","article-title":"[On the effect of N-phthalyl-glutamic acid imide on other drugs]","volume":"9","author":"Osterloh","year":"1959","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.crphar.2022.100138_bib120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jns.2007.03.010","article-title":"Thalidomide inhibits pentylenetetrazole-induced seizures","volume":"258","author":"Palencia","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib121","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuro.2015.02.004","article-title":"Neuroprotective effect of thalidomide on MPTP-induced toxicity","volume":"47","author":"Palencia","year":"2015","journal-title":"Neurotoxicity"},{"key":"10.1016\/j.crphar.2022.100138_bib122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eplepsyres.2010.10.003","article-title":"Thalidomide for treatment of refractory epilepsy","volume":"92","author":"Palencia","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.crphar.2022.100138_bib123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eplepsyres.2011.04.008","article-title":"Strong anticonvulsant effects of thalidomide on amygdaloid kindling","volume":"95","author":"Palencia","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.crphar.2022.100138_bib124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yebeh.2014.03.020","article-title":"Nitric oxide mediates the anticonvulsant effects of thalidomide on pentylenetertazole -induced clonic seizures in mice","volume":"34","author":"Payandemehr","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.crphar.2022.100138_bib125","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.3390\/molecules25235683","article-title":"Antiangiogenic activity and in silico cereblon binding analysis of novel thalidomide analogs","volume":"25","author":"Peach","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.crphar.2022.100138_bib126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D35FK5W0QV","article-title":"Review of thalidomide's history and current dermatological applications","volume":"9","author":"Perri","year":"2003","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.crphar.2022.100138_bib127","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12688\/wellcomeopenres.14818.1","article-title":"Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: a nested case-control study","volume":"3","author":"Petry","year":"2018","journal-title":"Wellcome Open Research"},{"key":"10.1016\/j.crphar.2022.100138_bib128","first-page":"e149","article-title":"Economic burden of nausea and vomiting of pregnancy in the USA","volume":"20","author":"Piwko","year":"2013","journal-title":"J.\u00a0Popul. Ther. Clin. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106362","article-title":"Anticonvulsant effects of thalidomide on pentlenetetrazole-induced seizure in mice: a role for opioidergic and nitrergic transmissions","volume":"164","author":"Pourshadi","year":"2020","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.crphar.2022.100138_bib130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-4328(96)00075-7","article-title":"Regulation of 5-HT release from enterochromaffin cells","volume":"73","author":"Racke","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.crphar.2022.100138_bib192","first-page":"1474","article-title":"Thalidomide has 37-year history","volume":"263","author":"Randall","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.crphar.2022.100138_bib131","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/2040620711413165","article-title":"The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development","volume":"2","author":"Rehman","year":"2011","journal-title":"Ther. Adv. Hematol"},{"key":"10.1016\/j.crphar.2022.100138_bib132","first-page":"CD008664","article-title":"Thalidomide for managing cancer cachexia","volume":"4","author":"Reid","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.crphar.2022.100138_bib133","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/tx9801817","article-title":"Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites","volume":"11","author":"Reist","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.crphar.2022.100138_bib134","article-title":"Involvement of the nitric oxide pathways in the anti-depressant -like effects of thalidomide in mice","volume":"208","author":"Rostamian","year":"2019","journal-title":"Phyiol. Behav."},{"key":"10.1016\/j.crphar.2022.100138_bib135","first-page":"243","article-title":"Thalidomide: clinical trial of a new hypnotic drug","volume":"20","author":"Salter","year":"1959","journal-title":"J.\u00a0Clin. Exp. Psychopathol. Q. Rev. Psychiatr. Neurol."},{"key":"10.1016\/j.crphar.2022.100138_bib136","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2011.03.009","article-title":"The translational value of rodent gastrointestinal functions: a cautionary tale","volume":"32","author":"Sanger","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib137","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fphar.2018.00913","article-title":"A\u00a0history of drug discovery for treatment of nausea and vomiting and the implications for future research","volume":"9","author":"Sanger","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib138","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15946","article-title":"A\u00a0proposal for rational drug class terminology: a gastrointestinal perspective","author":"Sanger","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib139","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09699260.1996.11746729","article-title":"Making sense of emesis, pruritus, 5-HT and 5-HT3 receptor antagonists","volume":"4","author":"Sanger","year":"1996","journal-title":"Prog. Palliat. Care"},{"key":"10.1016\/j.crphar.2022.100138_bib140","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.crphar.2022.100138_bib195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/med.21627","article-title":"Repurposing approved drugs on the pathway to novel therapies","volume":"40","author":"Schein","year":"2020","journal-title":"Med. Res. Rev"},{"key":"10.1016\/j.crphar.2022.100138_bib141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bmb\/ldaa045","article-title":"Repurposing approved drugs for cancer therapy","volume":"137","author":"Schein","year":"2021","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.crphar.2022.100138_bib142","first-page":"324","article-title":"The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution","volume":"25","author":"Schumacher","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib143","first-page":"338","article-title":"The metabolism of thalidomide.: the fate of thalidomide and some of its hydrolysis products in various species","volume":"25","author":"Schumacher","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib144","series-title":"Nausea and Vomiting: Mechanisms and Treatment","article-title":"Neurochemical investigations into the human area postrema. p18-30","author":"Schwartz","year":"1986"},{"key":"10.1016\/j.crphar.2022.100138_bib145","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1111\/bph.15916","article-title":"Perspective article: a proposal for rational drug class terminology","volume":"179","author":"Seifert","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.trsl.2007.05.003","article-title":"Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia","volume":"150","author":"Shannon","year":"2007","journal-title":"Transl. Res."},{"key":"10.1016\/j.crphar.2022.100138_bib147","first-page":"5767","article-title":"Therapeutic potential of thalidomide and its analogues in the treatment of cancer","volume":"35","author":"Sherbet","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.crphar.2022.100138_bib148","article-title":"Cereblon: a protein crucial to the multiple functions of immunomodulatory drugs as well as cell metabolism and disease generation","volume":"9130608","author":"Shi","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.crphar.2022.100138_bib149","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1248\/cpb.52.498","article-title":"Thalidomide as a nitric oxide synthase inhibitor and its structural development","volume":"52","author":"Shimazawa","year":"2004","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.crphar.2022.100138_bib150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-6980(74)90008-2","article-title":"Toxicology of the prostaglandins","volume":"7","author":"Smith","year":"1974","journal-title":"Prostaglandins"},{"key":"10.1016\/j.crphar.2022.100138_bib151","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/000992286600500417","article-title":"The thalidomide syndrome comprehensive care","volume":"5","author":"Smithells","year":"1966","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.crphar.2022.100138_bib152","series-title":"Drug Discovery. A History. Chapter 26","first-page":"355","author":"Sneader","year":"2005"},{"key":"10.1016\/j.crphar.2022.100138_bib153","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5381.1960.tb01217.x","article-title":"Pharmacological properties of thalidomide (alpha-phthalimido glutarimide), a new sedative hypnotic drug","volume":"15","author":"Somers","year":"1960","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.crphar.2022.100138_bib154","series-title":"Dark Remedy. The Impact of Thalidomide and its Revival as a Vital Medicine","first-page":"216","author":"Stephens","year":"2001"},{"key":"10.1016\/j.crphar.2022.100138_bib186","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1085-5629(98)80019-9","article-title":"Thalidomide and its impact in dermatology","volume":"17","author":"Stirling","year":"1988","journal-title":"Semin. Cutan. Med. Surg."},{"issue":"3","key":"10.1016\/j.crphar.2022.100138_bib155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0037-1963(00)90077-5","article-title":"Pharmacology of thalidomide","volume":"37","author":"Stirling","year":"2000","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.crphar.2022.100138_bib156","series-title":"Nausea: Mechanisms and Management","first-page":"462","author":"Stern","year":"2011"},{"key":"10.1016\/j.crphar.2022.100138_bib157","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(01)02049-3","article-title":"Effects of acetylcholine and GABA on neurons in the area postrema of Suncus murinus brainstem slices","volume":"309","author":"Strominger","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.crphar.2022.100138_bib159","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1111\/bcp.14792","article-title":"Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: hints on molecular action","volume":"87","author":"Sundaresan","year":"2020","journal-title":"Br J. Clin. Phrmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib158","series-title":"Suffer the Children-The Story of Thalidomide","first-page":"396","year":"1980"},{"issue":"Suppl. 2","key":"10.1016\/j.crphar.2022.100138_bib160","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.1016\/S2666-1683(20)33243-2","article-title":"Inhibition of human prostate smooth muscle contraction by thalidomide: a novel remedy in LUTS?","volume":"19","author":"Tamalunas","year":"2020","journal-title":"Eur. Urol. Open. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib161","first-page":"629","article-title":"Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section","volume":"73","author":"Tarhan","year":"2007","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.crphar.2022.100138_bib162","first-page":"981","article-title":"Chronology of the thalidomide story","volume":"87","author":"Theoret","year":"1962","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.crphar.2022.100138_bib163","doi-asserted-by":"crossref","DOI":"10.1177\/009127009903901108","article-title":"Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers","volume":"39","author":"Teo","year":"1999","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib164","first-page":"336","article-title":"L\u2019impiego dell\u2019imide dell\u2019acido N-ftalilglutammico (Talidomide) nella terapia sintomatica del vomito di molti pazienti affetti di neoplasia maligne o causato dalla somministrazione di cloridato di mecloretamina","volume":"18","author":"Traldi","year":"1965","journal-title":"Cancro"},{"key":"10.1016\/j.crphar.2022.100138_bib165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/0929867003375335","article-title":"Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery","volume":"7","author":"Trapani","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.crphar.2022.100138_bib166","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses","volume":"35","author":"Tseng","year":"1996","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.crphar.2022.100138_bib167","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res. (Part C)"},{"key":"10.1016\/j.crphar.2022.100138_bib168","first-page":"88","article-title":"The teratogenic effects of thalidomide on limbs","volume":"44","author":"Vargesson","year":"2019","journal-title":"J.\u00a0Hand Surg."},{"key":"10.1016\/j.crphar.2022.100138_bib169","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/14740338.2021.1991307","article-title":"Thalidomide: history, withdrawal, renaissance, and safety concerns","volume":"20","author":"Vargesson","year":"2021","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.crphar.2022.100138_bib170","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.7150\/jca.45678","article-title":"Efficacy and safety of thalidomide for chemotherapy-induced nausea and vomiting","volume":"11","author":"Wang","year":"2020","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.crphar.2022.100138_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.750507","article-title":"Mechanisms of chemotherapy-induced neurotoxicity","volume":"13","author":"Was","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib172","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bcp.14914","article-title":"Ethical issues in therapeutic use and research in pregnant and breastfeeding women","volume":"88","author":"Weld","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100138_bib173","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/01443619209025932","article-title":"Characterisation of nausea and vomiting in early pregnancy: a survey of 1,000 women","volume":"12","author":"Whitehead","year":"1992","journal-title":"J.\u00a0Obstet. Gynaecol."},{"key":"10.1016\/j.crphar.2022.100138_bib174","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1520-636X(1996)8:5<390::AID-CHIR6>3.0.CO;2-I","article-title":"Enatioselective inhibition of THF-alpha release by thalidomide and thalidomide-analogues","volume":"8","author":"Wnendt","year":"1996","journal-title":"Chirality"},{"key":"10.1016\/j.crphar.2022.100138_bib175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.10.010","article-title":"Tumour necrosis factor-\u03b1, interleukin 1\u03b2 and nitric oxide induce calcium transients in distinct populations of cells cultured from the rat area postrema","volume":"206","author":"Wuchert","year":"2009","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.crphar.2022.100138_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.818839","article-title":"Efficacy and safety of thalidomide as a pre-medication of chemotherapy-induced nausea and vomiting (CINV) following highly emetogenic chemotherapy (HEC): a systematic review and meta-analysis","volume":"11","author":"Xie","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib177","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11033-007-9077-3","article-title":"Primary function analysis if human mental retardation related gene CRBN","volume":"35","author":"Xin","year":"2008","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.crphar.2022.100138_bib178","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D2CS00116K","article-title":"Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders","volume":"51","author":"Yamamoto","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.crphar.2022.100138_bib179","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1253\/circj.CJ-18-0775","article-title":"A\u00a0lesson from the thalidomide tragedy","volume":"82","author":"Yashiro","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.crphar.2022.100138_bib180","series-title":"Nausea and Vomiting: Mechanisms and Treatment","article-title":"Mechanisms and treatment of radiation-induced nausea d vomiting. p94-109","author":"Young","year":"1986"},{"key":"10.1016\/j.crphar.2022.100138_bib181","first-page":"1","article-title":"Efficacy of thalidomide in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy: a randomized, multicentre, double-blind, placebo -controlled phase III trial (CLOG1302 study)","volume":"35","author":"Zhang","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib182","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1200\/JCO.2017.76.5784","article-title":"Reply to M.F. Chong et al","volume":"36","author":"Zhang","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.crphar.2022.100138_bib183","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3389\/fendo.2018.00793","article-title":"Elevated serum growth differentiation factor 15 levels in hyperthyroid patients","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.crphar.2022.100138_bib184","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.3390\/ijms22115797","article-title":"Mechanisms of nausea and vomiting: current knowledge and recent advances in intracellular emetic signalling systems","volume":"22","author":"Zhong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2022.100138_bib185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2015.11.023","article-title":"Thapasigarin -induced activation of Ca(2+) -CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew","volume":"103","author":"Zhong","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259025712200058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259025712200058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:53:59Z","timestamp":1762923239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259025712200058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":193,"alternative-id":["S259025712200058X"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100138","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100138"}}